137 related articles for article (PubMed ID: 8328041)
1. [Parallel import of drug preparations. A study of price development of parallel import preparations versus original preparations].
Schou HS
Ugeskr Laeger; 1993 Jun; 155(26):2024-8. PubMed ID: 8328041
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacists' and general practitioners' views on parallel import of drugs].
Gundersen R; Torgauten O; Olsen H
Tidsskr Nor Laegeforen; 1999 Apr; 119(11):1586-8. PubMed ID: 10385799
[TBL] [Abstract][Full Text] [Related]
3. [The market of synonymous preparations in Denmark 1985-1990. A comparison of prices and quantities on the market].
Nissen A
Ugeskr Laeger; 1991 Dec; 153(50):3558-62. PubMed ID: 1776198
[TBL] [Abstract][Full Text] [Related]
4. [Price development of oral contraceptives].
Minarcíková I
Ceska Slov Farm; 2005 Sep; 54(5):220-5. PubMed ID: 16209436
[TBL] [Abstract][Full Text] [Related]
5. The impact of generic substitution on price competition in Finland.
Aalto-Setälä V
Eur J Health Econ; 2008 May; 9(2):185-91. PubMed ID: 17508226
[TBL] [Abstract][Full Text] [Related]
6. [Parallel import of drugs].
Rygnestad T; Fredriksen G; Spigset O
Tidsskr Nor Laegeforen; 1999 Apr; 119(11):1573. PubMed ID: 10385794
[No Abstract] [Full Text] [Related]
7. Effect of generic drug competition on the price of prescription drugs in Ontario.
Lexchin J
CMAJ; 1993 Jan; 148(1):35-8. PubMed ID: 8439888
[TBL] [Abstract][Full Text] [Related]
8. Effect of multiple-source entry on price competition after patent expiration in the pharmaceutical industry.
Suh DC; Manning WG; Schondelmeyer S; Hadsall RS
Health Serv Res; 2000 Jun; 35(2):529-47. PubMed ID: 10857475
[TBL] [Abstract][Full Text] [Related]
9. The effect of generic competition on the price of brand-name drugs.
Lexchin J
Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
[TBL] [Abstract][Full Text] [Related]
10. [Parallel import of drugs for better and for worse].
Krabbe U
Ugeskr Laeger; 2004 Feb; 166(7):611. PubMed ID: 15005051
[No Abstract] [Full Text] [Related]
11. Price regulation and generic competition in the pharmaceutical market.
Dalen DM; Strøm S; Haabeth T
Eur J Health Econ; 2006 Sep; 7(3):208-14. PubMed ID: 16841230
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacoeconomics--survey and status].
Pedersen KM
Ugeskr Laeger; 2003 Apr; 165(16):1670-4. PubMed ID: 12756827
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical price differences in the EU: investigation from cardiovascular disease drugs.
Timur A; Picone G
Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):251-6. PubMed ID: 19527097
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical promotion and GP prescription behaviour.
Windmeijer F; de Laat E; Douven R; Mot E
Health Econ; 2006 Jan; 15(1):5-18. PubMed ID: 15945041
[TBL] [Abstract][Full Text] [Related]
15. Parallel imports and the pricing of pharmaceutical products: evidence from the European Union.
Ganslandt M; Maskus KE
J Health Econ; 2004 Sep; 23(5):1035-57. PubMed ID: 15353192
[TBL] [Abstract][Full Text] [Related]
16. Why drug prices will go lower.
Tully S
Fortune; 1993 May; 127(9):56-8, 60, 62 passim. PubMed ID: 10125261
[TBL] [Abstract][Full Text] [Related]
17. Does reimportation reduce price differences for prescription drugs? Lessons from the European Union.
Kyle MK; Allsbrook JS; Schulman KA
Health Serv Res; 2008 Aug; 43(4):1308-24. PubMed ID: 18355258
[TBL] [Abstract][Full Text] [Related]
18. A vision of the pharmaceutical industry.
Muñio S
Methods Find Exp Clin Pharmacol; 1998; 20 Suppl A():5-9. PubMed ID: 9800720
[TBL] [Abstract][Full Text] [Related]
19. [An analysis of the pharmaceuticals market in Vietnam].
Simonet D
Sante; 2001; 11(3):155-60. PubMed ID: 11641078
[TBL] [Abstract][Full Text] [Related]
20. [Strategies for pharmaceutical research and development. II. Generic drugs].
Kuchar M
Ceska Slov Farm; 1996 Jul; 45(4):171-6. PubMed ID: 8925240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
